Germany – Pharmaceutical products – Arzneimittel mit der Bezeichnung Botox(R) (ATC: M03AX21)

The subject of this publication is the conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V), for finished medicinal products designated Botox® (ATC: M03AX21) within the framework of an "open-house model." Under uniform contractual terms and a uniform access procedure, all suitable and interested pharmaceutical companies or consortia of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement pursuant to Section 130a Paragraph 8 of the SGB V for the aforementioned active ingredients or medicinal products. Interested pharmaceutical companies can request the participation documents and the respective contract from the contact address provided. A prerequisite for concluding a contract is that the interested pharmaceutical company has fully completed and signed the requested participation documents.